Lalo Flores, CEO at Century Therapeutics, on Developing Next-Generation Cell Therapies

In this episode, we sat down with Dr. Osvaldo (Lalo) Flores, CEO at Century Therapeutics. We discuss Lalo's early career in R&D, the founding story (and eventual acquisition) of Novira Therapeutics, and his outlook on next-generation cell therapies with Century.

Century Therapeutics is a biotechnology company developing transformative allogeneic cell therapies to create products for both hematological and solid tumor malignancies. In January 2022, Century entered into a strategic collaboration with Bristol Myers Squibb (BMS) to develop induced pluripotent stem cell (IPSC)-derived allogeneic cell therapies. Century is based in Philadelphia, PA.